Clinical trials
Recruiting Lung Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 5 |
| 2024 | 8 |
| 2025 | 16 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 45 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Sydney | 5 |
| Pfizer | 4 |
| BioNTech SE | 2 |
| Bristol-Myers Squibb | 2 |
| Eli Lilly and Company | 2 |
| Revolution Medicines, Inc. | 2 |
| TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) | 2 |
| Amgen | 1 |
| Apollomics Inc. | 1 |
| ArriVent BioPharma, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 45 |
| Carcinoma, Non-Small-Cell Lung | 28 |
| Breast Neoplasms | 9 |
| Pancreatic Neoplasms | 9 |
| Colorectal Neoplasms | 8 |
| Neoplasm Metastasis | 8 |
| Carcinoma | 7 |
| Neoplasms | 7 |
| Head and Neck Neoplasms | 6 |
| Lung Diseases | 6 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.